Related Experiment Videos
Mechanism-based therapy for leukemia: a lesson from ATRA therapy
1Department of Infectious Diseases, Nagoya University Graduate School of Medicine, Japan. tnaoe@med.nagoya-u.ac.jp
Nagoya Journal of Medical Science
|February 1, 2002
Summary
Molecular insights into human leukemias have advanced significantly, revealing deregulated cell processes caused by gene alterations. All-trans retinoic acid therapy for acute promyelocytic leukemia exemplifies successful oncoprotein-directed treatment, guiding future leukemia therapies.
Area of Science:
- Hematology
- Molecular Biology
- Oncology
Background:
- Leukemias are characterized by deregulated cell proliferation, differentiation, and apoptosis.
- Gene alterations, including chromosomal translocations, are key in leukemia development.
- Understanding molecular mechanisms offers potential drug development targets.
Purpose of the Study:
- To review the advancements in understanding leukemia's molecular mechanisms.
- To highlight the significance of targeted therapies like all-trans retinoic acid.
- To discuss future directions in acute myeloid leukemia therapy based on ATRA-resistance research.
Main Methods:
- Review of molecular mechanisms in leukemia.
- Analysis of gene alterations and their role.
- Examination of differentiation therapy and oncoprotein-directed therapy.
Main Results:
- Leukemias are understood as molecularly driven diseases.
- All-trans retinoic acid (ATRA) therapy for acute promyelocytic leukemia is a successful oncoprotein-directed therapy.
- Research into ATRA-resistance is informing new acute myeloid leukemia treatment strategies.
Conclusions:
- Molecular understanding has revolutionized leukemia treatment.
- Targeted therapies represent a major advancement in chemotherapy.
- Continued research into resistance mechanisms will drive future anti-leukemia strategies.